Skip to content

Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography

Objective, Prospective Measurement of Anterior Chamber Cell Grading Using Anterior Chamber Ocular Coherence Tomography

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02907814
Enrollment
6
Registered
2016-09-20
Start date
2016-09-30
Completion date
2018-04-30
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Keywords

Uveitis, Optical Coherence Tomography

Brief summary

Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.

Interventions

DEVICEOptical Coherence Tomography (OCT)

The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.

This is a brief, non-contact ocular exam.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age over 18 years old * Intervention Arm: * Active anterior chamber inflammation in at least one eye as diagnosed by clinical exam * One of the following: 1) diagnosis of uveitis OR 2) undergone cataract extraction surgery within the previous 30 days * Control Arm: * No active intraocular inflammation based on clinical exam

Exclusion criteria

* Corneal opacities in the affected eye * Anyone judged unable to understand or consent to study participation

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Identified Inflammatory Cells on OCT ScanThrough study completion, up to 1 year.This measure pertains to the identification of cells in OCT scan of the participants. The inflammatory cells to be identified refer to white blood cells. The anterior segment OCT scan was used to attempt to identify these cells in the anterior chamber of the eyes of the participants.

Secondary

MeasureTime frameDescription
Change in Cell Density Identified by OCT Scans Over TimeBaseline and up to 8 weeks.Identification of changes in cell density in OCT scans over time

Countries

United States

Participant flow

Recruitment details

Ophthalmology clinic, Newark, New Jersey, from 10/26/2016 to 4/1/2018

Participants by arm

ArmCount
Uveitis and Cataract Imaging Group
Subjects will undergo up to three optical coherence tomography scans. Optical Coherence Tomography (OCT): The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.
6
Control
Control subjects will undergo a brief, non-contact eye exam and then undergo up to three optical coherence tomography scans. Optical Coherence Tomography (OCT): The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed. Eye Exam: This is a brief, non-contact ocular exam.
0
Total6

Baseline characteristics

CharacteristicTotalUveitis and Cataract Imaging Group
Age, Continuous40 years
STANDARD_DEVIATION 12.5
40 years
STANDARD_DEVIATION 12.5
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
6 participants6 participants
Sex: Female, Male
Female
4 Participants4 Participants
Sex: Female, Male
Male
2 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 0
other
Total, other adverse events
0 / 60 / 0
serious
Total, serious adverse events
0 / 60 / 0

Outcome results

Primary

Number of Participants With Identified Inflammatory Cells on OCT Scan

This measure pertains to the identification of cells in OCT scan of the participants. The inflammatory cells to be identified refer to white blood cells. The anterior segment OCT scan was used to attempt to identify these cells in the anterior chamber of the eyes of the participants.

Time frame: Through study completion, up to 1 year.

Population: Patients with uveitis identified from clinic.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Uveitis and Cataract Imaging GroupNumber of Participants With Identified Inflammatory Cells on OCT Scan6 Participants
Secondary

Change in Cell Density Identified by OCT Scans Over Time

Identification of changes in cell density in OCT scans over time

Time frame: Baseline and up to 8 weeks.

Population: 0 of 6 patients had follow up data, unable to identify change over time.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026